Harnessing Pathology of Pulmonary Hypertension to Therapeutic Advantage

All credits to Marlene Rabinovitch FPVRI, Professor of Pediatrics, at Stanford University School of Medicine, in Stanford- California | United States

Presented at the 1st Annual Drug Discovery and Development Symposium, July 14-15th 2014, Bethesda, USA

Additional key-words: endothelin receptor antagonists,BMPR2,PPARgamma,p53

About the author

Professor of Pediatrics

Stanford University

United States